Intriguingly, FOXM1, a transcription factor whose stability and transcriptional activity are increased by HMGA1 in TNBC cells [67] confers chemoresistance to paclitaxel and trastuzumab through the upregulation of stathmin in BC cells [57]. Here, STMN1 is linked to breast cancer.